Multi-omics characterization and therapeutic liability of ferroptosis in melanoma

被引：18
|
作者：
He, Yi [1 ]
Dong, Yu [2 ]
Chen, Yong [3 ,4 ]
Zhang, Guanxiong [1 ]
Zhang, Hailun [5 ]
Lei, Guang [6 ,7 ]
Du, Yanhua [2 ]
Chen, Xiang [1 ]
Ye, Youqiong [2 ]
Liu, Hong [1 ]
机构：
[1] Cent South Univ, Xiangya Clin Res Ctr Canc Immunotherapy, Hunan Key Lab Skin Canc & Psoriasis,Dept Dermatol, Hunan Engn Res Ctr Skin Hlth & Dis,Xiangya Hosp, Changsha, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Shanghai Inst Immunol, Shanghai, Peoples R China
[3] Fudan Univ, Shanghai Canc Ctr, Dept Musculoskeletal Surg, Shanghai, Peoples R China
[4] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[5] Beijing GAP Biotechnol Co Ltd, Dept Res & Dev, Beijing, Peoples R China
[6] Cent South Univ, Hunan Canc Hosp, Dept Radiat Oncol, Changsha, Peoples R China
[7] Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Peoples R China
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2022年 / 7卷 / 01期
基金：
中国国家自然科学基金; 中国博士后科学基金;
关键词：
D O I：
10.1038/s41392-022-01067-y
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Multi-omics and tumor immune microenvironment characterization of a prognostic model based on aging-related genes in melanoma
    He, Zhenghao
    Chen, Manli
    Li, Qianwen
    Luo, Zhijun
    Li, Xidie
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (03):
  • [42] Integrative multi-omics characterization reveals sex differences in glioblastoma
    Jang, Byunghyun
    Yoon, Dayoung
    Lee, Ji Yoon
    Kim, Jiwon
    Hong, Jisoo
    Koo, Harim
    Sa, Jason K.
    BIOLOGY OF SEX DIFFERENCES, 2024, 15 (01)
  • [43] Multi-omics characterization of chemo-refractory HGSC patients
    Muranen, Taru A.
    Rajavuori, Anna
    Afenteva, Daria
    Huhtinen, Kaisa
    Isoviita, Veli-Matti
    Jamalzadeh, Sanaz
    Lahtinen, Alexandra
    Lavikka, Kari
    Li, Yilin
    Marchi, Giovanni
    Oikkonen, Jaana
    Zhang, Kaiyang
    Virtanen, Anni
    Hynninen, Johanna
    Hautaniemi, Sampsa
    CANCER RESEARCH, 2023, 83 (07)
  • [44] Multi-omics insights and therapeutic implications in polycystic ovary syndrome: a review
    Babu, Achsha
    Ramanathan, Gnanasambandan
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2023, 23 (02)
  • [45] Multi-omics characterization of claudin-low breast tumors
    Pommier, Roxane M.
    Morel, Anne-Pierre
    Tissier, Agnes
    Thomas, Emilie
    Kielbassa, Janice
    Tonon, Laurie
    Sohier, Emilie
    Viari, Alain
    Saintigny, Pierre
    Puisieux, Alain
    CANCER RESEARCH, 2018, 78 (04)
  • [46] Multi-omics and single cell characterization of cancer immunosenescence landscape
    Wei, Qiuxia
    Chen, Ruizhi
    He, Xue
    Qu, Yanan
    Yan, Changjian
    Liu, Xiaoni
    Liu, Jing
    Luo, Jiahao
    Yu, Zining
    Hu, Wenping
    Wang, Liqun
    Lin, Xiaoya
    Wu, Chaoling
    Xiao, Jinyuan
    Zhou, Haibo
    Wang, Jing
    Zhu, Mingxia
    Yang, Ping
    Chen, Yingtong
    Tan, Qilong
    Yuan, Xiaoliang
    Jing, Hongmei
    Zhang, Weilong
    SCIENTIFIC DATA, 2024, 11 (01)
  • [47] Multi-omics insights and therapeutic implications in polycystic ovary syndrome: a review
    Achsha Babu
    Gnanasambandan Ramanathan
    Functional & Integrative Genomics, 2023, 23
  • [48] Integrative multi-omics characterization reveals sex differences in glioblastoma
    Byunghyun Jang
    Dayoung Yoon
    Ji Yoon Lee
    Jiwon Kim
    Jisoo Hong
    Harim Koo
    Jason K. Sa
    Biology of Sex Differences, 15
  • [49] Integrated multi-omics characterization of KRAS mutant colorectal cancer
    Chong, Wei
    Zhu, Xingyu
    Ren, Huicheng
    Ye, Chunshui
    Xu, Kang
    Wang, Zhe
    Jia, Shengtao
    Shang, Liang
    Li, Leping
    Chen, Hao
    THERANOSTICS, 2022, 12 (11): : 5138 - 5154
  • [50] Multi-omics characterization of an inflammatory bowel disease mouse model
    Han, Qiyuan
    Kono, Thomas
    Knutson, Charles
    Seiler, Christopher
    Tretyakova, Natalia
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
12345